source
- Digital health firms eye CMS ACCESS Medicare pilot despite modest reimbursementA new Medicare initiative called CMS ACCESS is being launched to manage chronic diseases among seniors. The program will contract digital health companies to provide remote monitoring and other se…
- Cyllene Therapeutics raises €33 million to pursue HSV-based gene therapy after Krystal modelCyllene Therapeutics, a French-US biotech, announced it has secured €33 million in financing. The capital will be used to develop HSV-based gene therapy programs, aiming to replicate the approach…